The invention relates to (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one for therapeutic purposes, pharmaceutical agents, and the use thereof in treatment, in particular for the prophylaxis and treatment of tumor diseases.